Health Systems, Economic Evaluations, Quality of Life

Работ: 58

1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

   Theo Vos, Stephen S Lim, Cristiana Abbafati +97

   СтатьяGlobal Maternal and Child HealthThe Lancet2020Цитирований: 12

   ABIABI:AkademIndex/openalex/2026.other.000036

2. Addressing the challenges of improving primary care quality in Uzbekistan: a qualitative study of Chronic Heart Failure management

   Mohir Ahmedov, John Green, Ravshan Azimov +3

   СтатьяHeart Failure Treatment and ManagementHealth Policy and Planning2012Цитирований: 2

   ABIABI:AkademIndex/openalex/2012.article.000085

3. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement

   Gretchen A Stevens, Leontine Alkema, Robert E. Black +16

   Обзорная статьяHealth Systems, Economic Evaluations, Quality of LifeThe Lancet2016Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.000012

4. GW28-e1018 Study of endpoints in patients with chronic heart failure to determine the prognosis

   U. K. Kamilova, Nuriddin Nuritdinov

   СтатьяDiabetes Management and ResearchJournal of the American College of Cardiology2017Цитирований: 1

   ABIABI:AkademIndex/openalex/2017.article.000245

5. Positionspapier zur Zertifizierung von Telemedizinzentren

   Thomas M. Helms, Christian Perings, Philipp Sommer +8

   СтатьяClinical practice guidelines implementationDer Kardiologe2021Цитирований: 1

   ABIABI:AkademIndex/openalex/2021.article.000470

6. National cancer control plans: a global analysis

   Yannick Romero, Dario Trapani, Sonali Johnson +7

   Обзорная статьяGlobal Cancer Incidence and ScreeningThe Lancet Oncology2018Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.000021

7. Core elements of national cancer control plans: a tool to support plan development and review

   Andrew Oar, Fábio Ynoe de Moraes, Yannick Romero +2

   Обзорная статьяGlobal Cancer Incidence and ScreeningThe Lancet Oncology2019Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.000027

8. Enhancing global access to cancer medicines

   Javier Cortés, José Manuel Pérez-García, Antonio Llombart‐Cussac +13

   Обзорная статьяEconomic and Financial Impacts of CancerCA A Cancer Journal for Clinicians2020Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.000031

9. A Status Report on the Health Care Sector in France

   N. Lalitha, Samira Guennif

   СтатьяPharmaceutical Economics and PolicyJournal of Health Management2008Цитирований: 0

   ABIABI:AkademIndex/openalex/2008.article.000392

10. Efficacy and safety of combined antihypertensive therapy with ramipril and moxonidine in patients with metabolic syndrome

    Jamol Uzokov, Aniskhon Lutfullayevich Alyavi, Ilhom Yunuskhonovich Akhmedov +2

    СтатьяBlood Pressure and Hypertension StudiesJournal of the American Society of Hypertension2016Цитирований: 0

    ABIABI:AkademIndex/openalex/2016.article.000281

11. TCTAP A-076 Prognosis of Unfavorable Outcomes in Patients with Heart Failure Combined with Diabetes Mellitus

    Mirzo Juraev

    СтатьяCardiovascular Function and Risk FactorsJournal of the American College of Cardiology2016Цитирований: 0

    ABIABI:AkademIndex/openalex/2016.article.000575

12. Compliance initiatives in management of patients with coronary artery disease and parkinsonism syndrome

    A. Shalaeva, N. Dadabaeva, M. Bozorboev +1

    СтатьяHealth Systems, Economic Evaluations, Quality of LifeAtherosclerosis2016Цитирований: 0

    ABIABI:AkademIndex/openalex/2016.article.000706

13. GW27-e1256 EFFICACY EVALUATION OF BETA BLOCKERS IN THE PATIENTS WITH CHRONIC HEART FAILURE IN RELATION TO THE STATE OF BETA1-ADRENORECEPTORS

    U. K. Kamilova, Tohirahon Alieva, Kodir Boboev

    СтатьяHormonal Regulation and HypertensionJournal of the American College of Cardiology2016Цитирований: 0

    ABIABI:AkademIndex/openalex/2016.article.000743

14. TCTAP A-157 Short Term Outcomes After Percutaneous Interventions in Patients with Metabolic Syndrome

    Jamol Uzokov, Anis Alyavi, Bakhrom Alyavi

    СтатьяHealth Systems, Economic Evaluations, Quality of LifeJournal of the American College of Cardiology2017Цитирований: 0

    ABIABI:AkademIndex/openalex/2017.article.000599

15. Compliance initiatives in management of patients with coronary artery disease after acute myocardial infarction

    A. Shalaeva, N. Dadabaeva

    СтатьяHealthcare cost, quality, practicesAtherosclerosis2017Цитирований: 0

    ABIABI:AkademIndex/openalex/2017.article.000691

16. P767Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment

    Aleksandr B. Shek, Р. Д. Курбанов, G J Abdullaeva +3

    СтатьяLipoproteins and Cardiovascular HealthEuropean Heart Journal2017Цитирований: 0

    ABIABI:AkademIndex/openalex/2017.article.000751

17. A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness Analysis

    S. Djalalov, Jaclyn Beca, Emmanuel M. Ewara +1

    СтатьяHealth Systems, Economic Evaluations, Quality of LifePharmacoEconomics2019Цитирований: 0

    ABIABI:AkademIndex/openalex/2019.article.000160

18. PCN252 QUALITY EVALUATION OF PHARMACOECONOMIC STUDIES IN RUSSIAN CANCER RESEARCH: AN OUTSIDE VIEW

    S. Djalalov, Dilfuza Djalalova, Murray Krahn +2

    СтатьяHealth Systems, Economic Evaluations, Quality of LifeValue in Health2019Цитирований: 0

    ABIABI:AkademIndex/openalex/2019.article.001253

19. Improving clinical practice in primary care for the prevention and control of noncommunicable diseases: a multi-actor approach to two regional pilot projects in Kazakhstan

    Erica Barbazza, Saltanat Yegeubayeva, Baktygul Akkazieva +3

    Обзорная статьяGlobal Public Health Policies and EpidemiologyCardiovascular Diagnosis and Therapy2019Цитирований: 0

    ABIABI:AkademIndex/openalex/2019.review-article.000011

20. Review of Pharmacoeconomic Studies in Russian Cancer Research: An Outside View

    S. Djalalov, Dilfuza Djalalova, Murray Krahn +2

    Обзорная статьяHealth Systems, Economic Evaluations, Quality of LifeValue in Health Regional Issues2019Цитирований: 0

    ABIABI:AkademIndex/openalex/2019.review-article.000012

21. Study of clinical efficiency and portability of the Pramipexol BIO product

    S. Musaev, Y. Musaeva, S. Xakimova

    СтатьяParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders2020Цитирований: 0

    ABIABI:AkademIndex/openalex/2020.article.003856

22. Assessment of depressive conditions in Parkinson's disease (PD) and the impact on the quality of life of patients

    A. Ismatov, D. Tolibov, М М Махмудов

    СтатьяParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders2020Цитирований: 0

    ABIABI:AkademIndex/openalex/2020.article.003952

23. Evaluation of the effectiveness and competitiveness of scientific and innovative activities of medical research organizations and medical universities

    Vitaliy Koikov, A Umbetzhanova, Amangali Akanov +3

    СтатьяHealth and Medical Research ImpactsJournal of Health Development2020Цитирований: 0

    ABIABI:AkademIndex/openalex/2020.article.005097

24. Reinforcing Adherence to Lipid-lowering Therapy after an Acute Coronary Syndrome: A Pragmatic Randomized Controlled Trial

    Stefanos Zafeiropoulos, Ioannis T. Farmakis, Αναστάσιος Κάρτας +6

    ПрепринтLipoproteins and Cardiovascular HealthResearch Square2020Цитирований: 0

    ABIABI:AkademIndex/openalex/2020.preprint.000048

25. Reinforcing Adherence to Lipid-lowering Therapy after an Acute Coronary Syndrome: A Pragmatic Randomized Controlled Trial

    Stefanos Zafeiropoulos, Ioannis T. Farmakis, George Giannakoulas +1

    ПрепринтLipoproteins and Cardiovascular HealthResearch Square2020Цитирований: 0

    ABIABI:AkademIndex/openalex/2020.preprint.000099